Myocardial Protection: Clinical Trials

2 trials for Myocardial Protection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Not yet recruiting 1

Follow Myocardial Protection: new trials by email Literature Review of Myocardial Protection trials Research Report on Myocardial Protection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass
Adenoseine, Placebo (sterile distilled water) - Myocardial Protection
Phase 4Not yet recruitingHospital Nossa Senhora da Conceicao602026-03-302026-02-23
Levosimendan and Myocardial Protection
levosimendan, Placebo - Myocardial Protection
Phase 4CompletedUniversity of Roma La Sapienza1002005-01-012008-02-07

Narrower conditions

Ischemia (1)

Broader conditions

Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Simendan (1)

Sponsors

Hospital Nossa Senhora da Conceicao (1)  ·  University of Roma La Sapienza (1)

Countries

Brazil (1)  ·  Italy (1)

Top investigators

Vincenzo De Santis, M.D. (1)

Results publications

PMID 10235522, PMID 11555521, PMID 12607714, PMID 17613242, PMID 19151048, PMID 22964356, PMID 26683400, PMID 29225152, PMID 30253969, PMID 31133354, PMID 31364690, PMID 34489276, PMID 34640503, PMID 38505015, PMID 9485282